How to Choose Safe Compounded Semaglutide: What Patients Should Know

Some pharmacies have been discovered adding sodium to semaglutide compounds. Shed stays focused on patient safety, ensuring the medications prescribed to patients are safe and that patients receive reliable care throughout their weight-loss journeys.

With the recent surge in demand for weight-loss medications, there have been semaglutide shortages with brands like Ozempic® and Wegovy®, leaving many wondering where to get their medications. Compounding pharmacies, like ones that Shed works with, remain a safe and sustainable solution. The FDA declared a prior semaglutide shortage resolved in February 2025, but market disruptions and new demand patterns have continued to drive confusion for consumers seeking trustworthy options. The FDA confirmed the semaglutide injection shortage was resolved on February 21, 2025 and published specific timelines describing when it would and would not exercise enforcement discretion for 503A and 503B compounders—a key context for understanding when compounded copies of branded GLP‑1 products are permitted or restricted (FDA enforcement‑discretion timeline and guidance).

There have been recent concerns about the authenticity of compounded versions of semaglutide. For instance, it has been discovered that some pharmacies use a sodium form of semaglutide base. However, the formulations Shed’s partner pharmacies compound and distribute do not add any kind of sodium to their products and never have. They work through licensed pharmacies and licensed pharmacies only.

Questions surrounding some compounding pharmacies using salt forms of semaglutide instead of the base form flagged by the FDA emphasizes the importance of choosing a trusted source. Shed works exclusively with licensed and compliant facilities that follow FDA directives, maintain required documentation, and protect the integrity of the medications they compound. Federal law (the Compounding Quality Act and the 503A/503B framework) defines different regulatory expectations for state‑licensed pharmacies versus FDA‑registered outsourcing facilities—including which facilities must follow cGMP‑style requirements and which are inspected by the FDA (Compounding Quality Act text). For background on how semaglutide works and why the base form matters, see everything you need to know about semaglutide.

The Shed Difference

The Highest Standards

Shed ensures that its partner pharmacies strictly adhere to quality standards, utilizing ingredients from reputable FDA-registered and FDA-inspected manufacturers, ensuring the potency, sterility, and safety of their compounded medications. They offer medications produced with semaglutide and tirzepatide, as well as other ingredients, like B12, which can promote weight loss and mitigate potential negative side effects. Because combinations like semaglutide and B12 have not been formally studied together, the Shed Care Team evaluates each ingredient’s safety profile and counsels patients individually.

Ingredients sourced from FDA-registered manufacturers with Certificates of Analysis
Sterility and potency testing for sterile, multi-dose vials to reduce contamination and dosing error risk
Clear labeling, safety seals, and standardized dosing tools, with medication options including injections, lozenges, tablets, and liquid drops

For patients seeking approved branded options, Shed also offers an FDA-approved path through a Wegovy membership or Zepbound membership, which clarifies the difference between branded products and compounded alternatives.

Patient-Focused

It may sometimes feel frustrating as an individual trying to decipher what is and is not legitimate. Shed prioritizes patient safety, ensuring transparency in their processes and instilling confidence in the medications prescribed to their customers. We provide upfront information about BMI recommendations as well as online provider consults. Patients should be upfront and honest about their medical history and goals to ensure these recommendations help them achieve their weight-loss goals. If someone does not hit BMI recommendations they are notified and offered other options from Shed.

Evidence-based criteria: BMI 30 or BMI 27 with a weight-related condition. Those with lower BMIs may qualify for Microdose GLP-1.
Structured titration plans and early follow-up, typically within 3 to 4 weeks.
Objective progress tracking, and adjustments based on labs and symptoms.

Randomized trials and meta-analyses show weekly subcutaneous semaglutide 2.4 mg produces large, sustained average weight loss (≈10–12% body weight or ~11–12 kg vs placebo) with gastrointestinal side effects the most common adverse events, supporting the expectations set during counseling (meta‑analysis of semaglutide 2.4 mg efficacy and safety).

If you are exploring treatment options, learn how outcomes compare in semaglutide vs. traditional weight-loss methods, and review real patient experiences in semaglutide weight-loss reviews.

The Best of the Best Health Care Providers

Qualified health care providers are here to meet, discuss, and track the progress of each patient so they are properly protected and cared for during each check-up appointment. The Shed Care Team is at the patient’s service 24 hours a day to answer questions and assist in any way they can.

As uncertainties and demand increase among compounding pharmacies, Shed emerges as a reliable and trustworthy source for weight-loss medications. In states with specific guidance, such as California, Shed operates through licensed, compliant partner pharmacies, as described in compounded semaglutide for Californians through Shed.

How to Verify Your Semaglutide Is Not a Sodium Salt

Patients can take a few simple steps before buying:

Ask the pharmacy to confirm in writing that the active ingredient is semaglutide base, not a salt form.
Request the Certificate of Analysis and verify the API supplier is FDA-registered.
Confirm the facility is licensed and that sterile products undergo lot-specific sterility and potency testing.
Avoid any seller that ships without a valid prescription or labels products “not for human consumption.”

What Quality Controls to Expect From Licensed Partners

Trustworthy compounding partners typically provide:

Documented sourcing of raw materials from FDA-registered manufacturers.
Sterility testing by validated methods and stability or potency checks for each lot.
Clear dosing tools to minimize error with multi-dose vials.
An adverse event reporting process and instructions for return-to-clinic when side effects occur.

Expect compounding partners to follow USP standards for sterile and nonsterile preparations (USP <797>, <795>), which set requirements for cleanrooms, personnel qualifications, sterility assurance, and lot‑specific testing to reduce contamination and dosing errors (USP announces new and revised compounding standards).

Clinical Oversight Patients Should Expect

Well-run programs include:

Baseline assessment, including BMI, medical history, and relevant labs.
An evidence-aligned titration plan, with early follow-up in 3 to 4 weeks.
Counseling on GI side effects and hypoglycemia risk if on insulin or sulfonylureas.
Documentation and informed consent, including cost transparency and alternatives.

Questions to Ask Your Provider or Pharmacy

Use these prompts before you start:

Do you confirm your product is semaglutide base and not a salt form?
Are your semaglutide ingredients sourced from FDA-registered manufacturers with a COA?
What sterility and potency tests are performed on each lot?
How will my dose be titrated and how soon is my first follow-up?
How do you handle adverse event reporting and missed doses?
If B12 is added, what is the rationale for my case and how is safety monitored?

FAQs

How can patients verify compounded semaglutide is not a sodium salt formulation?

Ask your pharmacy to attest that the active ingredient is semaglutide base. Request the Certificate of Analysis showing the API identity and source. Shed’s partner pharmacies do not add sodium; they source APIs from FDA-registered manufacturers, with documentation available for patient review. For a primer on the drug itself, see everything you need to know about semaglutide.

Why choose a licensed compounding pharmacy that follows FDA directives?

Licensure and compliance increase transparency and safety. Licensed pharmacies must document sourcing, compounding processes, and testing. Shed works only with licensed and compliant partner pharmacies that follow FDA guidance, provide quality documentation, and support clinical oversight throughout care. Federal law sets the statutory framework that differentiates state‑licensed pharmacies from FDA‑registered outsourcing facilities and clarifies inspection and quality expectations (Compounding Quality Act text).

What quality controls should I expect for semaglutide or semaglutide with B12?

Expect ingredient verification from FDA-registered suppliers, batch-specific sterility and potency testing, and clear labeling. If B12 is included, Shed providers discuss the rationale, contraindications, and monitoring plan, since semaglutide and B12 have not been formally studied in combination. Compounding partners should adhere to USP compounding standards for sterile and nonsterile preparations to reduce contamination and dosing errors (USP announces new and revised compounding standards).

How do FDA-inspected manufacturers and licensure affect safety?

APIs from FDA-registered and inspected manufacturers come with validated testing and Certificates of Analysis, which support consistency and potency. Shed requires this level of documentation from partner pharmacies to help ensure patients receive safe, high-quality medications.

What clinical oversight and follow-up should I expect with compounded semaglutide?

Shed provides BMI screening, an evidence-based titration plan, and early follow-up within 3 to 4 weeks to review side effects and labs. The Shed Care Team offers support between visits and uses adverse event reporting when needed.

When facing shortages, are compounded options still appropriate?

The FDA reported the previous shortage resolved in 2025, but access issues can persist. When approved options are not available or appropriate, Shed evaluates the risks and benefits of compounded alternatives through licensed partners and provides transparency about sourcing, testing, and costs. Patients who qualify may also consider a Wegovy membership or Zepbound membership.

Do patients in specific states have different options?

Some states have unique regulatory requirements. Shed works with licensed, compliant partner pharmacies in each state and keeps patients informed about options, such as availability of lozenges and injections in Mississippi and state-specific updates like compounded semaglutide for Californians.

Where can I read more about outcomes and patient experiences?

For clinical comparisons, see semaglutide vs. traditional weight-loss methods. For social proof and real-world perspectives, read semaglutide weight-loss reviews. Shed integrates these insights into patient counseling and care plans.